PFIZER DAUNORUBICIN daunorubicin (as hydrochloride) 18.7 mg powder for injection vial

מדינה: אוסטרליה

שפה: אנגלית

מקור: Department of Health (Therapeutic Goods Administration)

מרכיב פעיל:

daunorubicin hydrochloride, Quantity: 20 mg (Equivalent: daunorubicin, Qty 18.7 mg)

זמין מ:

Pfizer Australia Pty Ltd

טופס פרצבטיות:

Injection, powder for

הרכב:

Excipient Ingredients: mannitol

מסלול נתינה (של תרופות):

Intravenous Infusion

יחידות באריזה:

1

סוג מרשם:

(S4) Prescription Only Medicine

סממני תרפויטית:

Pfizer Daunorubicin Powder for Injection is indicated for the treatment of the following:,Acute lymphocytic (lymphoblastic) leukaemia,Daunorubicin is usually reserved for use in cases shown to be resistant to other drugs. However, combined treatment with daunorubicin, vincristine and a steroid has been used in the early stages of this disease.,Acute myeloblastic leukaemia,Daunorubicin has been used in all stages, alone or in combination with other cytotoxic agents (e.g., cytarabine).,Disseminated solid tumours,Daunorubicin has been investigated for use in these tumours and found to be effective in some cases of disseminated neuroblastoma and rhabdomyosarcoma.

leaflet_short:

Visual Identification: Colourless glass vials containing a porous, red-orange freeze-dried cake or mass; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius

מצב אישור:

Registered

תאריך אישור:

2023-09-01